Skip to content

Good News For Protalix BioTherapeutics’ Orphan Drug Elelyso For Gaucher Disease

September 27, 2012

       Good news for Protalix BioTherapeutics’ orphan drug Elelyso for Gaucher Disease.

       Per the September 27, 2012 Protalix BioTherapeutics News Release, orphan drug Elelyso receives marketing authorization for the treatment of adults with Type 1 Gaucher Disease from the Israeli Ministry of Health. 

Copyright  © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog.  All rights reserved.

Advertisements
Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: